SER Stock Analysis: Buy, Sell, or Hold?
SER - Serina Therapeutics, Inc.
$1.79
0.03 (1.70%)
▲
5d:
-0.56%
30d:
-5.79%
90d:
+7.19%
BUY
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 14, 2026
0d
Get Alerted When SER Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SER shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: SER shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: SER is currently trading at $1.79, which is considered fair relative to its 30-day fair value range of $1.66 to $1.89.
Technical Outlook: Technically, SER is in a strong downtrend. Immediate support is located at $1.55, while resistance sits at $2.03.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.00 (+514.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SER is in a strong downtrend. Immediate support is located at $1.55, while resistance sits at $2.03.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.00 (+514.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.66 -
$1.89
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 514.5% below Wall St target ($11.00)
Trading Range Analysis
30-Day Trading Range
$1.66 -
$1.89
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.55
Resistance Level
$2.03
Current Trend
Strong Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.70
Wall Street Target
$11.00
(+514.5%)
Revenue Growth (YoY)
154.9%
Earnings Growth (YoY)
-43.5%
Share & Embed Analysis
Last updated: June 03, 2026 8:40 PM ET
Data refreshes hourly during market hours. Next update: 9:40 PM
Data refreshes hourly during market hours. Next update: 9:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SER showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$55 | 66 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 58 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$548 | 53 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 55 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 53 HOLD |
